These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 3974099)

  • 1. Consensus conference. Lowering blood cholesterol to prevent heart disease.
    JAMA; 1985 Apr; 253(14):2080-6. PubMed ID: 3974099
    [No Abstract]   [Full Text] [Related]  

  • 2. Lowering blood cholesterol to prevent heart disease. NIH Consensus Development Conference statement.
    Arteriosclerosis; 1985; 5(4):404-12. PubMed ID: 3839391
    [No Abstract]   [Full Text] [Related]  

  • 3. Reassessment of the value of lowering serum cholesterol. Questioning the wisdom of widespread intervention.
    Labreche DG
    Clin Pharm; 1988 Aug; 7(8):592-603. PubMed ID: 3048850
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholesterol and coronary heart disease: screening and treatment.
    Ebrahim S; Smith GD; McCabe C; Payne N; Pickin M; Sheldon TA; Lampe F; Sampson F; Ward S; Wannamthee G
    Qual Health Care; 1998 Dec; 7(4):232-9. PubMed ID: 10339027
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program.
    Grundy SM; Cleeman JI; Rifkind BM; Kuller LH
    Arch Intern Med; 1999 Aug 9-23; 159(15):1670-8. PubMed ID: 10448768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic intervention for hypercholesterolemia.
    Gotto AM
    Clin Cardiol; 1992 Nov; 15(11 Suppl 3):III18-21; discussion III22-4. PubMed ID: 1477993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipid therapy. Goal and use in prevention of coronary heart disease].
    Windler E; Greten H
    Internist (Berl); 1996 Dec; 37(12):1244-8. PubMed ID: 9081925
    [No Abstract]   [Full Text] [Related]  

  • 8. A need to redefine the consensus on the use of statins in coronary heart disease prevention.
    Fruchart JC
    Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008
    [No Abstract]   [Full Text] [Related]  

  • 9. Introduction: missing the target with lipid-lowering therapy.
    Hunninghake DB; McKenney JM
    Am J Manag Care; 2000 Nov; 6(19 Suppl):S992-6. PubMed ID: 11187370
    [No Abstract]   [Full Text] [Related]  

  • 10. Getting tough with cholesterol.
    Harv Heart Lett; 1998 Feb; 8(6):1-4. PubMed ID: 9516312
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cholesterol: how and when to treat it?].
    Masana Marín L
    Med Clin (Barc); 1985 Oct; 85(10):423-5. PubMed ID: 4079497
    [No Abstract]   [Full Text] [Related]  

  • 12. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of coronary artery disease: the south Asian paradox.
    Tunstall-Pedoe S; Starkey C; Mathews B; Hilton S; Cappuccio FP
    Lancet; 2003 Jan; 361(9351):79-80. PubMed ID: 12517495
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypercholesterolemia in elderly persons: resolving the treatment dilemma.
    Denke MA; Grundy SM
    Ann Intern Med; 1990 May; 112(10):780-92. PubMed ID: 2184712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of cholesterol-lowering drugs in prevention of coronary heart disease].
    Skałuba Z; Undas R
    Przegl Lek; 1998; 55(7-8):382-7. PubMed ID: 10021881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The special cholesterol concerns of women.
    Johns Hopkins Med Lett Health After 50; 2000 Sep; 12(7):4-5. PubMed ID: 10948881
    [No Abstract]   [Full Text] [Related]  

  • 17. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An affirmative view.
    Crouch MA
    J Fam Pract; 1988 Jun; 26(6):665-70. PubMed ID: 3379369
    [No Abstract]   [Full Text] [Related]  

  • 18. [Benefits and costs of early detection and treatment of hypercholesterolemia].
    Laaser U
    Z Kardiol; 1994; 83 Suppl 6():163-7. PubMed ID: 7863690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipid-lowering therapy in the prevention of coronary heart disease].
    Keller U
    Schweiz Rundsch Med Prax; 1990 Sep; 79(39):1120-4. PubMed ID: 2218247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of hypercholesterolemia with enzyme inhibitors].
    Valdés EF
    Medicina (B Aires); 1988; 48(4):425-8. PubMed ID: 3076202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.